Cantú syndrome

From WikiMD's WELLNESSPEDIA


Cantú syndrome
Synonyms Hypertrichotic osteochondrodysplasia
Pronounce N/A
Specialty N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Cantú syndrome is a rare genetic disorder characterized by hypertrichosis, osteochondrodysplasia, and cardiovascular abnormalities. It is also known as hypertrichotic osteochondrodysplasia.

Signs and Symptoms[edit]

Individuals with Cantú syndrome typically present with excessive hair growth (hypertrichosis), distinctive facial features, cardiomegaly (enlarged heart), and skeletal abnormalities. Other symptoms may include macrocephaly (large head size), edema (swelling), and developmental delay.

Genetics[edit]

Cantú syndrome is caused by mutations in the ABCC9 gene, which encodes the sulfonylurea receptor 2 (SUR2), a component of ATP-sensitive potassium channels. These mutations lead to dysregulation of potassium ion flow, affecting various bodily systems.

Diagnosis[edit]

Diagnosis of Cantú syndrome is based on clinical evaluation, identification of characteristic features, and genetic testing to confirm mutations in the ABCC9 gene. Genetic counseling is recommended for affected families.

Treatment[edit]

There is no cure for Cantú syndrome, and treatment is symptomatic and supportive. Management may involve a multidisciplinary team including cardiologists, endocrinologists, and geneticists. Regular monitoring of cardiovascular health is crucial.

Epidemiology[edit]

Cantú syndrome is extremely rare, with fewer than 50 cases reported in the medical literature. It affects both males and females equally.

See Also[edit]

References[edit]


External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.